147 related articles for article (PubMed ID: 36261813)
1. Observation on clinical effect of Huoxue-Jiangtang decoction formula granules in treating prediabetes: a randomized prospective placebo-controlled double-blind trial protocol.
Zhang PX; Zeng L; Meng L; Li HL; Zhao HX; Liu DL
BMC Complement Med Ther; 2022 Oct; 22(1):274. PubMed ID: 36261813
[TBL] [Abstract][Full Text] [Related]
2. The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design.
Sun X; Guo L; Shang H; Ren M; Wang Y; Huo D; Lei X; Wang H; Zhai J
Trials; 2015 Nov; 16():496. PubMed ID: 26530718
[TBL] [Abstract][Full Text] [Related]
3. Huoxue Jiangtang Decoction Alleviates Type 2 Diabetes Mellitus by Regulating the Oral Microbiota and Food Preferences.
Huang Q; Meng L; Li H; Xiong N; Zeng L; Wang G; Zhang P; Zhao H; Liu D
Diabetes Metab Syndr Obes; 2022; 15():3739-3751. PubMed ID: 36474726
[TBL] [Abstract][Full Text] [Related]
4. A Randomized Controlled Clinical Trial of Lifestyle Intervention and Pioglitazone for Normalization of Glucose Status in Chinese with Prediabetes.
Luo Y; Wang H; Zhou X; Chang C; Chen W; Guo X; Yang J; Ji L; Paul SK
J Diabetes Res; 2022; 2022():2971382. PubMed ID: 35036447
[TBL] [Abstract][Full Text] [Related]
5. Rationale, Design, and Baseline Characteristics of Beijing Prediabetes Reversion Program: A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Lifestyle Intervention and/or Pioglitazone in Reversion to Normal Glucose Tolerance in Prediabetes.
Luo Y; Paul SK; Zhou X; Chang C; Chen W; Guo X; Yang J; Ji L; Wang H
J Diabetes Res; 2017; 2017():7602408. PubMed ID: 28168204
[No Abstract] [Full Text] [Related]
6. JinQi-Jiangtang tablet, a Chinese patent medicine, for pre-diabetes: a randomized controlled trial.
Cao H; Ren M; Guo L; Shang H; Zhang J; Song Y; Wang H; Wang B; Li X; Hu J; Wang X; Wang D; Chen J; Li S; Chen L
Trials; 2010 Mar; 11():27. PubMed ID: 20214831
[TBL] [Abstract][Full Text] [Related]
7. Polyherbal dietary supplementation for prediabetic adults: study protocol for a randomized controlled trial.
Feinberg T; Wieland LS; Miller LE; Munir K; Pollin TI; Shuldiner AR; Amoils S; Gallagher L; Bahr-Robertson M; D'Adamo CR
Trials; 2019 Jan; 20(1):24. PubMed ID: 30616613
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the effeCt of lIfestyle iNtervention plus water-soluble ciNnAMon extract On loweriNg blood glucose in pre-diabetics, a randomized, double-blind, multicenter, placebo controlled trial: study protocol for a randomized controlled trial.
Crawford P; Thai C; Obholz J; Schievenin J; True M; Shah SA; Hallgren J; Clark J; Sharon D
Trials; 2016 Jan; 17():9. PubMed ID: 26732017
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and safety of bifidobacteria and berberine in people with hyperglycemia: study protocol for a randomized controlled trial.
Ming J; Xu S; Liu C; Liu X; Jia A; Ji Q
Trials; 2018 Jan; 19(1):72. PubMed ID: 29373989
[TBL] [Abstract][Full Text] [Related]
10. Effect of RG (Coptis root and ginseng) formula in patients with type 2 diabetes mellitus: a study protocol for a randomized controlled and double-blinding trial.
Jiang L; Fu Q; Wang S; Chen Y; Li J; Xiao Y; Sun R; Shen EA; Wang J; Zhang Y; Li Z; Liu J; Fu X; Liu Y; Zhao Y; Su G; Huang W; Zhao J
Trials; 2022 Apr; 23(1):305. PubMed ID: 35422046
[TBL] [Abstract][Full Text] [Related]
11. Chinese herbal medicine Tianqi reduces progression from impaired glucose tolerance to diabetes: a double-blind, randomized, placebo-controlled, multicenter trial.
Lian F; Li G; Chen X; Wang X; Piao C; Wang J; Hong Y; Ba Z; Wu S; Zhou X; Lang J; Liu Y; Zhang R; Hao J; Zhu Z; Li H; Fang Liu H; Cao A; Yan Z; An Y; Bai Y; Wang Q; Zhen Z; Yu C; Wang CZ; Yuan CS; Tong X
J Clin Endocrinol Metab; 2014 Feb; 99(2):648-55. PubMed ID: 24432995
[TBL] [Abstract][Full Text] [Related]
12. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.
le Roux CW; Astrup A; Fujioka K; Greenway F; Lau DCW; Van Gaal L; Ortiz RV; Wilding JPH; Skjøth TV; Manning LS; Pi-Sunyer X;
Lancet; 2017 Apr; 389(10077):1399-1409. PubMed ID: 28237263
[TBL] [Abstract][Full Text] [Related]
13. Screening for Prediabetes and Type 2 Diabetes in Children and Adolescents: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Jonas DE; Vander Schaaf EB; Riley S; Allison BA; Middleton JC; Baker C; Ali R; Voisin CE; LeBlanc ES
JAMA; 2022 Sep; 328(10):968-979. PubMed ID: 36098720
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the Safety and Efficacy of Sodium-Glucose Co-transporter 2 Inhibitors in Subjects with Prediabetes: A Protocol for a Randomized Controlled Trial.
Zhu X; Xia L; Yin D; Yang J; Wei R
Diabetes Ther; 2024 May; 15(5):1231-1244. PubMed ID: 38494571
[TBL] [Abstract][Full Text] [Related]
15. Effects of α-Cyclodextrin on Cholesterol Control and Hydrolyzed Ginseng Extract on Glycemic Control in People With Prediabetes: A Randomized Clinical Trial.
Bessell E; Fuller NR; Markovic TP; Lau NS; Burk J; Hendy C; Picone T; Li A; Caterson ID
JAMA Netw Open; 2020 Nov; 3(11):e2023491. PubMed ID: 33201232
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus: A Randomized Trial.
Cusi K; Orsak B; Bril F; Lomonaco R; Hecht J; Ortiz-Lopez C; Tio F; Hardies J; Darland C; Musi N; Webb A; Portillo-Sanchez P
Ann Intern Med; 2016 Sep; 165(5):305-15. PubMed ID: 27322798
[TBL] [Abstract][Full Text] [Related]
17. The effect of a novel probiotic on metabolic biomarkers in adults with prediabetes and recently diagnosed type 2 diabetes mellitus: study protocol for a randomized controlled trial.
Palacios T; Vitetta L; Coulson S; Madigan CD; Denyer GS; Caterson ID
Trials; 2017 Jan; 18(1):7. PubMed ID: 28069054
[TBL] [Abstract][Full Text] [Related]
18. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study.
Perreault L; Pan Q; Mather KJ; Watson KE; Hamman RF; Kahn SE;
Lancet; 2012 Jun; 379(9833):2243-51. PubMed ID: 22683134
[TBL] [Abstract][Full Text] [Related]
19. Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF).
Lee MMY; Brooksbank KJM; Wetherall K; Mangion K; Roditi G; Campbell RT; Berry C; Chong V; Coyle L; Docherty KF; Dreisbach JG; Labinjoh C; Lang NN; Lennie V; McConnachie A; Murphy CL; Petrie CJ; Petrie JR; Speirits IA; Sourbron S; Welsh P; Woodward R; Radjenovic A; Mark PB; McMurray JJV; Jhund PS; Petrie MC; Sattar N
Circulation; 2021 Feb; 143(6):516-525. PubMed ID: 33186500
[TBL] [Abstract][Full Text] [Related]
20. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
